Study also indicates early treatment may provide best outcomes.
Study also indicates early treatment may provide best outcomes.
With FDA approval of EpidiolexR, the pace of research on CBD medication is likely to increase.
Tests of NT-3 gene therapy on mouse models suggest potential to treat a host of muscle-wasting conditions.
A new study shows that cannabidiol is effective in children with Lennox-Gastaut syndrome.
Recent applications of adeno-associated virus (AAV) mediated gene therapy have focused mainly on correcting recessively inherited diseases. But what about dominantly inherited disorders? It looks like AAV could be a delivery mechanism for treating those genetic disorders, too.
